Targeting FAK in anticancer combination therapies
JC Dawson, A Serrels, DG Stupack… - Nature Reviews …, 2021 - nature.com
Focal adhesion kinase (FAK) is both a non-receptor tyrosine kinase and an adaptor protein
that primarily regulates adhesion signalling and cell migration, but FAK can also promote …
that primarily regulates adhesion signalling and cell migration, but FAK can also promote …
Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer
X Geng, H Chen, L Zhao, J Hu, W Yang, G Li… - Frontiers in cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease that typically features a
dramatic desmoplastic reaction, especially fibroblasts. The roles of cancer-associated …
dramatic desmoplastic reaction, especially fibroblasts. The roles of cancer-associated …
Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance
Z Guo, M Ashrafizadeh, W Zhang, R Zou… - Cancer and metastasis …, 2024 - Springer
The metastasis is a multistep process in which a small proportion of cancer cells are
detached from the colony to enter into blood cells for obtaining a new place for metastasis …
detached from the colony to enter into blood cells for obtaining a new place for metastasis …
Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?
I Belhabib, S Zaghdoudi, C Lac, C Bousquet, C Jean - Cancers, 2021 - mdpi.com
Simple Summary Stroma modifications observed in solid cancer are now recognized as
critical events for cancer progression and as potential therapeutic or diagnostic targets. The …
critical events for cancer progression and as potential therapeutic or diagnostic targets. The …
Combinatorial therapy in tumor microenvironment: where do we stand?
The tumor microenvironment plays a pivotal role in tumor initiation and progression by
creating a dynamic interaction with cancer cells. The tumor microenvironment consists of …
creating a dynamic interaction with cancer cells. The tumor microenvironment consists of …
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year overall survival rate. Patients
with PDAC display limited benefits after undergoing chemotherapy or immunotherapy …
with PDAC display limited benefits after undergoing chemotherapy or immunotherapy …
[HTML][HTML] ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node …
R Sun, L Yuan, Y Jiang, Y Wan, X Ma, J Yang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Lymph node (LN) metastasis is common in patients with epithelial ovarian
cancer (EOC) and is associated with poor prognosis. Tumor-associated lymphangiogenesis …
cancer (EOC) and is associated with poor prognosis. Tumor-associated lymphangiogenesis …
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
YH Zhu, JH Zheng, QY Jia, ZH Duan, HF Yao, J Yang… - Cellular Oncology, 2023 - Springer
Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is
characterized by poor treatment response and low survival time. The current clinical …
characterized by poor treatment response and low survival time. The current clinical …
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis
D Ozmadenci… - Proceedings of the …, 2022 - National Acad Sciences
High-grade serous ovarian cancer (HGSOC) is a lethal malignancy characterized by an
immunosuppressive tumor microenvironment containing few tumor infiltrating lymphocytes …
immunosuppressive tumor microenvironment containing few tumor infiltrating lymphocytes …
Transcytosis mediated deep tumor penetration for enhanced chemotherapy and immune activation of pancreatic cancer
H Chen, H Song, Y Luo, C Li, Y Wang… - Advanced Functional …, 2023 - Wiley Online Library
The hyperproliferative tumor stroma of pancreatic ductal adenocarcinoma (PDAC) severely
limits drug permeation and constructs an immunosuppressive microenvironment, causing …
limits drug permeation and constructs an immunosuppressive microenvironment, causing …